Difference between revisions of "Vortioxetine-tranylcypromine"

From Psychiatrienet
Jump to: navigation, search
 
Line 5: Line 5:
 
{{stopVortioxetine}}
 
{{stopVortioxetine}}
 
| start =  
 
| start =  
* '''Day 8-21:''' a wash-out period of two weeks is necessary.
+
* '''Day 8-21:''' a wash-out period of two weeks is necessary.<ref name="vortiswitch"> {{Pubmed|24570588 |Katona et al. New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder. 2014 2014 Feb 19;10:349-54}}</ref> <ref name="informatorium">{{KNMP|vortioxetine}}</ref>
 
* '''Day 22:''' Start administration of tranylcypromine in low dosage of 20 mg/day for one week.
 
* '''Day 22:''' Start administration of tranylcypromine in low dosage of 20 mg/day for one week.
 
* '''Day 29:''' after this week the dosage of tranylcypromine can be increased if necessary.  
 
* '''Day 29:''' after this week the dosage of tranylcypromine can be increased if necessary.  

Latest revision as of 16:16, 4 November 2015

Vortioxetine
Type Antidepressant
Group SMS
links
Medscape Vortioxetine
PubChem 9966051
PubMed Vortioxetine
Kompas (Dutch) Vortioxetine
Wikipedia Vortioxetine
Tranylcypromine
Type Antidepressant
Group MAO-I
links
Medscape Tranylcypromine
PubChem 5530
PubMed Tranylcypromine
Wikipedia Tranylcypromine

Switch medication from vortioxetine to tranylcypromine.

Nietinrijdenbord.png Stop vortioxetine
  • Day 1: reduce dosage of vortioxetine to 5 mg/day.
  • Day 8: stop administration of vortioxetine.
Eenrichtingbord.png Start tranylcypromine
  • Day 8-21: a wash-out period of two weeks is necessary.[1] [2]
  • Day 22: Start administration of tranylcypromine in low dosage of 20 mg/day for one week.
  • Day 29: after this week the dosage of tranylcypromine can be increased if necessary.
Letopbord.png Cave


The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.